Unassociated Document

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) 
November 11, 2010
 
ALLIED HEALTHCARE PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
 
 
Delaware 
0-19266 
25-1370721 
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)

1720 Sublette Avenue, St. Louis, Missouri 
63110
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code 
(314) 771-2400 
  
Not applicable 
(Former name or former address, if changed since last report) 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

ITEM 5.07. Submission of Matters to a Vote of Security Holders.
 
The annual meeting of the stockholders of Allied Healthcare Products, Inc. (the “Company”) was held on November 11, 2010. Proxies were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934.  There was no solicitation in opposition to management’s nominees for Directors and all nominees were elected.  The voting results in the election of directors, which was the only matter submitted to a vote, is noted below.
 
 
PROPOSAL 1: ELECTION OF DIRECTORS
 
 
For
Withheld
Broker Non-Votes
       
Judith T. Graves
6,654,621
14,543
NA
William A. Peck
6,654,746
14,418
NA
Earl R. Refsland q
6,654,026
15,137
NA
Joseph E. Root
6,654,686
14,478
NA
John D. Weil
6,628,845
40,319
NA
 
 
 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
  ALLIED HEALTHCARE PRODUCTS, INC.  
       
Date:  November 22, 2010     
By:
/s/ Daniel C. Dunn  
    Daniel C. Dunn  
    Chief Financial Officer